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Abstract
Background: Preventing recurrence of depression forms an important challenge for current treatments. Cognitive
control impairments often remain present during remission of depression, putting remitted depressed patients at
heightened risk for new depressive episodes by disrupting emotion regulation processes. Importantly, research indicates
that cognitive control training targeting working memory functioning shows potential in reducing maladaptive emotion
regulation and depressive symptomatology in clinically depressed patients and at-risk student samples. The current study
aims to test the effectiveness of cognitive control training as a preventive intervention in a remitted depressed sample,
exploring effects of cognitive control training on rumination and depressive symptomatology, along with indicators of
adaptive emotion regulation and functioning.
Methods/design: We present a double blind randomized controlled design. Remitted depressed adults will complete 10
online sessions of a cognitive control training targeting working memory functioning or a low cognitive load training
(active control condition) over a period of 14 days. Effects of training on primary outcome measures of rumination and
depressive symptomatology will be assessed pre-post training and at three months follow-up, along with secondary
outcome measure adaptive emotion regulation. Long-term effects of cognitive control training on broader indicators of
functioning will be assessed at three months follow-up (secondary outcome measures).
Discussion: This study will provide information about the effectiveness of cognitive control training for remitted
depressed adults in reducing vulnerability for depression. Furthermore, this study will address key questions concerning
the mechanisms underlying the effects of cognitive control training, will take into account the subjective experience of
the patients (including a self-report measure for cognitive functioning), and explore whether these effects extend to broad
measures of functioning such as Quality of Life and disability.
Trial registration: This study is registered with ClinicalTrials.Gov, number NCT02407652.
Keywords: Cognitive control, Training, Rumination, Depression, Remitted depressed, Relapse prevention, Randomized
controlled trial
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Background
Improving the effectiveness of psychotherapeutic inter-
ventions for depression forms an important challenge
for depression research. That is, patients who initially re-
spond successful to therapy, often show residual symp-
toms which increases the chance of recurrence of
depressive episodes. Moreover, existing treatments are
less effective for chronic depression [1] and not all de-
pressive symptoms show an equal response to treatment
[2]. For instance, cognitive symptoms such as impaired
executive- and working memory functioning and their
biological substrates often remain present although the
patient is considered to be in remission (e.g., [3, 4]). Im-
portantly, it has been suggested that reduced cognitive
functioning — i.e., impaired regulation of working mem-
ory, or ‘cognitive control’ — is not merely a byproduct
of depression, but places remitted depressed (RMD) pa-
tients in a distinct vulnerable position for recurrence of
depression [5, 6].
Indeed, the number of previous depressive episodes
shows a negative correlation with behavioral indices of
cognitive control [7]. Furthermore, prospective studies
suggest that self-reported cognitive control impairments
[8] and their behavioral indices [9] predict the develop-
ment of future depressive symptomatology. Interestingly,
impaired cognitive control has typically been linked to
maladaptive emotion regulation strategies such as ru-
mination [9–11], an important cognitive vulnerability
factor for depression [12]. Especially brooding — a sub-
type of rumination that is characterized by a passive
style of moody pondering — has shown to predict the
occurrence of future depressive symptomatology [13].
Importantly, prospective studies indicate that the use of
maladaptive emotion regulation strategies link impaired
cognitive control to the development of future depres-
sive symptomatology in RMD [14]. Thus, via maladap-
tive emotion regulation cognitive control impairments
convey an important risk for recurrent depression (but
see [15]). Moreover, this mechanism is believed to sus-
tain and increase biological and cognitive vulnerability
for recurrent depression (for a review, see [6]).
In accordance with studies indicating plasticity of ex-
ecutive and working memory functioning [16], these
findings have led researchers to try to remediate cogni-
tive control impairments in depression using cognitive
training tasks. In a pilot study, Siegle et al. [17] demon-
strated that combining treatment as usual (TAU) with a
cognitive control training (CCT) shows potential in re-
ducing rumination as well as depressive symptomatology
in a limited MDD sample. The CCT existed of the adap-
tive Paced Auditory Serial Addition Task (PASAT; [18])
and Well’s Attention training [19]. Furthermore, Siegle
et al. [20] have extended these findings, showing long
term beneficial effects of CCT by demonstrating a
reduced need for outpatient services at one year follow-up.
Interestingly, whereas previous studies have demonstrated
the potential of a combined CCT approach [17, 20–22],
other authors have shown that the training component tar-
geting working memory functioning (the adaptive PASAT)
might suffice to reduce brooding [23] and depressive
symptomatology [24] in MDD patients.
These first experimental findings are in line with existing
conceptual frameworks concerning the role of cognitive
control and rumination in recurrent depression [6, 25],
suggesting that by remediating cognitive control impair-
ments, one might decrease cognitive vulnerability for
future depression. Accordingly, Siegle et al. [20] have sug-
gested that effects of CCT on depressive symptomatology
are preceded by changes in rumination. However, to date
no experimental study has directly tested this mediation ef-
fect. Furthermore, previous studies have typically explored
curative effects of CCT in MDD patients whereas only
more recently the preventive potential of CCT has been
explored in student populations. For instance, in a single
session cognitive control manipulation, Cohen et al. [26]
have demonstrated that inducing cognitive control while
processing negative information buffers against negative ef-
fects of a subsequent rumination induction procedure (i.e.,
state rumination, rumination-related sad mood). Moreover,
training inhibition of emotional information has shown to
reduce rumination in at-risk students [27]. Interestingly,
researchers have found that the adaptive PASAT shows
promise in reducing stress reactivity and rumination in re-
sponse to a lab stressor directly following training and a
naturalistic stressor at one month follow-up in an at-risk
student sample [28]. Furthermore, decreased stress reactiv-
ity in confrontation with a lab stressor predicted lower
brooding levels following confrontation with naturalistic
stress (i.e., examination period). These findings suggest that
CCT targeting working memory functioning shows poten-
tial as a preventive intervention for depression.
Rational for the proposed study
Previous studies indicate that the effects of CCT are not
limited to the mere reduction of current depressive symp-
tomatology in MDD patients, but might also extend to in-
creasing resilience in at-risk populations. However, several
theoretical gaps remain to be addressed.
First, in order to fully explore the potential of CCT tar-
geting working memory functioning in reducing (cogni-
tive) vulnerability for depression, a test of training effects
in a RMD sample would be desirable. That is, RMD pa-
tients form a high-risk group for developing future de-
pressive episodes [29] and prospective studies indicate
that impaired cognitive control forms an important vul-
nerability factor in RMD [14]. Second, from a theoretical
stance it would be interesting to explore the proposed me-
diational pathway from effects of CCT on rumination to
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reduced future depressive symptomatology. Third, with
the exception of Siegle et al. [20] who explored effects of
CCT on outpatient service use, previous studies have lim-
ited their scope to exploring effects of CCT on rumination
and depressive symptomatology. We aim at extending
previous findings by also exploring effects of CCT on
adaptive emotion regulation as well as broader indicators
of (dis-)functioning such as experienced disability, experi-
enced remission from depression, and Quality of Life. Fur-
thermore, we are not only interested in change in behavior
indices of cognitive control, but also in the clinical experi-
ence of RMD patients concerning these cognitive factors
(e.g., self-report measures of executive- and working mem-
ory functioning). Finally, in order to reduce sources of bias
in exploring the potential of CCT as a preventive interven-
tion, a rigid methodological approach — i.e., a double-
blind randomized controlled trial (RCT) — is required.
Method
Design
We present a 2 (Condition) x 3 (Time) double blind,
randomized controlled design. Adult RMD participants
will be randomly allocated to either an online CCT
intervention targeting working memory functioning or a
low cognitive load training (active control condition).
Both groups will perform 10 online training sessions
over a period of 14 days, flanked by pre- and post-
training lab assessments. Participants will return to the
lab for a final assessment at three months follow-up (see
Fig. 1 for an overview of the design). This study has been
approved by the local ethical committee of the Faculty
of Psychology and Educational Sciences of Ghent Uni-
versity and was registered with ClinicalTrials.gov, num-
ber NCT02407652.
Participants
Inclusion and exclusion criteria
To be eligible for participation to this study, participants
aged between 23 and 65 should report a history of depres-
sion (at least one prior depressive episode) and report
stable (partial) remission (≥6 months). Consequently, par-
ticipants should not meet criteria for a current depressive
episode before starting training as assessed by the Mini-
International Neuropsychiatric Interview (MINI; [30]).
However, they should meet the criteria for a previous epi-
sode. The depressive episode should not have occurred in
the context of a bipolar disorder. Neither should the par-
ticipant report a history of psychosis, excessive substance
abuse, or report experiencing cognitive impairments due
to brain injury. A history of other comorbid disorders is
allowed — yet these should not lead to current impair-
ments — in order to increase the clinical relevance and
validity of our study. Therapeutic maintenance contact
(with a frequency less than once per three weeks) and use
of antidepressant medication is allowed and will be regis-
tered. Importantly, antidepressant medication should be
kept at a constant level throughout the course of the study.
Recruitment
RMD participants will be recruited using advertisements
in popular (online) magazines and newspapers as well as
flyers that were placed in 106 local drugstores (Ghent
area). Furthermore, drawing on an existing database, 23
potentially interested participants will be contacted based
on their interest in a prior prospective study of our lab (at
that point, all of these participants had given their permis-
sion to be re-contacted in case a related study was
planned). After having expressed interest in this study (i.e.,
by phone or e-mail), participants will be contacted by
phone to provide further information and to screen eligi-
bility based on a selection of relevant questions of the
MINI screening version. To screen whether participants
show a history of depression, we will ask questions con-
cerning current and previous depressive symptoms, and
collect information concerning the amount of episodes
and past as well as current treatment. Furthermore, we
will check whether (professional or similar) activities were
resumed following the last depressive episode. If the par-
ticipant seems eligible and is interested in participating in
the study, he or she will be invited to the lab for a struc-
tured clinical interview (MINI). In the lab, the MINI
screening version will be used to check for indicators of
currently present comorbid disorders and — if this proves
to be necessary — will be followed by the corresponding
parts of the MINI interview to allow to control for pres-
ence of comorbid disorders. The parts related to MDD
will be fully assessed to assure that participants do not
meet the criteria for MDD before entering the study.
Meeting eligibility criteria will allow the participant to en-
roll in the study, starting immediately with randomization
over one of both conditions and the baseline assessment.
Measures
Primary outcome measures
Rumination and depressive symptomatology form our
primary outcome measures. Rumination will be assessed
using the Ruminative Response Scale (RRS; [13, 31]).
This 22-item questionnaire provides a total rumination
score (range: 22 – 88), as well as Brooding and Reflec-
tion subscale scores (range: 5 – 20). Brooding is charac-
terized by a passive style of moody pondering and is the
most maladaptive form of depressive rumination [13,
32]. Depressive symptomatology will be assessed using
the 21-item (range: 0 – 63) Beck Depression Inventory
(BDI-II; [33, 34]). Both primary outcome measures ex-
hibit adequate psychometric properties [13, 33, 34].
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Secondary outcome measures
Adaptive emotion regulation and indicators of RMD func-
tioning will be our secondary outcome measures. Adap-
tive emotion regulation will be assessed using the five
adaptive subscales of the Cognitive Emotion Regulation
Questionnaire (CERQ; [35]). The four less adaptive strat-
egies (self-blame, rumination, catastrophizing, and blam-
ing others) can be used as a second, alternative measure
for maladaptive emotion regulation (range: 4 – 20).
Functioning will be operationalized by indices of dis-
ability, quality of life, resilience, and remission from de-
pression. Disability will be assessed using the self-report
version of the World Health Organization Disability As-
sessment Schedule 2.0 (WHODAS 2.0; [36]), consisting
of 36 items. This measure is based on the conceptual
framework of the International Classification of Func-
tioning (ICF) and provides indicators of overall function-
ing and six specific domains of functioning (Cognition,
Mobility, Self-care, Getting along, Life activities, and Par-
ticipation). Furthermore, the questionnaire provides an es-
timate of the amount of days in the past month during
which the difficulties (a) were present, (b) prevented the
participant from performing his/her daily activities or
work, or (c) formed a source of reduced functioning.
Quality of life will be assessed using the depression-
specific 34-item (range: 0 – 34) Quality of Life in Depres-
sion Scale (QLDS; [37, 38]. Resilience will be assessed using
the Resilience Scale (RS; [39, 40]). We will use the 25-item
version of the RS using four point Likert-scales (range: 25
– 100). Finally, self-reported remission from depression will
be assessed using the 41-item Remission of Depression
Questionnaire (RDQ; [41]; Dutch translation: Peeters et al.:
RDQ-NL, unpublished document) for which a high score
is indicative for more psychopathology (range: 0 – 82).
Manipulation check, training process and cognitive transfer
measures
As a manipulation check and process measure, training
task performance will be assessed in both conditions using
median inter stimulus interval (ISI) levels per training ses-
sion. Furthermore, as a process measure of effects of com-
pleting an online training session, mood (‘energetic’, ‘tense’,
‘frustrated’, ‘sad’, ‘happy’) will be assessed using visual
analogue scales (VAS; 1 – 100). The extent to which par-
ticipants have experienced negative thoughts and stress
throughout the training session will also be assessed using
VAS, along with experienced task competence (‘During
the task I felt as if I was doing great’). It has been sug-
gested that training cognitive control in a frustrating task-
context — and thus, eliciting low levels of negative affect
First assessment of eligibility 
(telephone interview)
Exclusion 
Second assessment of eligibility 




10 online CCT sessions 
(14 days) 
10 online low cognitive load 
training sessions (14 days) 
Post-training assessment 
3 months follow-up assessment  
Exclusion 
Fig. 1 Study flowchart
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while training — contributes to the beneficial effects of
CCT [28]. These process measures allow to explore the
mechanism underlying CCT. Furthermore, we will use the
Credibility/Expectancy Questionnaire (CEQ; [42]; Dutch
translation: Godfrin et al.: CEQ-NL, unpublished docu-
ment) to check for baseline group differences in treatment
credibility/expectancy and to check for successful blinding
of participants (post-training). Moreover, we will monitor
intake of antidepressants and other forms of therapy as
well as stressful life events that might influence our find-
ings. For the latter, we will use the List of Threatening Ex-
periences (LTE; [43, 44]).
Close transfer to cognitive control will be assessed using
the non-adaptive PASAT [18]. During this task, participants
are presented with a practice phase consisting of 10 trials,
followed by a test phase, consisting of three blocks with in-
creasing difficulty (ISI block 1 = 3000 ms; ISI block 2 =
2000 ms; ISI block 3 = 1500 ms), each containing 60 trials.
Furthermore, we will include the Behavior Rating Inventory
of Executive Function Adult version (BRIEF-A; [45]) as a
self-report measure to assess experienced cognitive control.
This 75-item self-report questionnaire provides several esti-
mates of executive and working memory functioning (e.g.,
inhibition, shifting, emotional control, working memory).
Interventions
Participants will either be subjected to an online CCT tar-
geting working memory functioning (the adaptive PASAT)
or a closely matched low cognitive load training. This al-
lows to rule out motivational aspects of performing an
adaptive computer task online. The tasks will be presented
in-browser, using a Millisecond software Web license. Both
training groups will be asked to perform 10 sessions of 400
trials (which takes 20 min per session at an average inter
stimulus interval (ISI) of 3000 ms), providing similar learn-
ing experiences in both conditions. Prior to training, both
groups will receive oral and written psycho-education con-
cerning cognitive control training (based on the protocol
of [17]) in order to enhance task engagement. This is im-
portant as previous work indicates that task engagement
forms an important predictor of response to CCT [20]. Im-
portantly, no explicit information will be given about the
to be expected results. Furthermore, participants will re-
ceive an automated text message on a daily basis to prevent
attrition during the training period (using SurveySignal
software; [46]).
Cognitive control training condition
We will use an adaptive version of the PASAT [17, 18] to
train participants’ cognitive control in the CCT condition.
Participants will be presented with a continuous stream of
auditory digits (1–9) and are instructed to immediately re-
spond to the sum of the last two heard digits by clicking
the corresponding response buttons (1–18). The speed of
number presentation is adapted based on participants’
performance in order to train cognitive control in a frus-
trating task context. Participants begin each session with a
3000 ms ISI, which is reduced by 100 ms following every
four consecutive correct responses, increasing task diffi-
culty. Following every four incorrect responses the ISI in-
creases with 100 ms, reducing task difficulty. Throughout
each session participants are presented with their current
ISI and amount of consecutive correct and incorrect re-
sponses. Participants’ responses and response times are
being measured. In line with previous training studies the
median ISI per session will be used as an indicator of ones
performance during the training sessions.
Active control condition
In the active control condition, participants will be pre-
sented with a low cognitive load version of the adaptive
PASAT. This training task shows high resemblance to the
adaptive PASAT concerning stimuli, responses, modifica-
tion of task difficulty, and evaluation of session perform-
ance. However, in this low cognitive load version of the
adaptive PASAT participants are instructed to immedi-
ately respond to the last heard digit instead of mentally
manipulating the content in working memory (i.e., instead
of responding to the sum of the last two heard digits as in
the CCT condition). To better resemble the response op-
tions of the adaptive PASAT, participants in the active
control condition are presented auditory stimuli ranging
from 1–18.
Sample size
We are the first to explore effects of CCT targeting
working memory functioning in a RMD sample which
makes it impossible to provide an exact estimate of ef-
fect size for the main outcome measure in this sample.
However, previous work on MDD patients has yielded
an effect size of ɳ2 = .19 for brooding [20], whereas work
with at-risk undergraduate students revealed an effect
size of ɳ2 = .11 in confrontation with naturalistic stress
[28]. Given that this study will use an at-risk sample
(RMD), we will base estimations of sample size on the
latter effect size. In order to be able to detect a similar ef-
fect over two time points with α = .05 and 1-β = .80, the
total sample size should at least be 68 (n CCT = 34, n
active control = 34). We will stop recruiting once 68 par-
ticipants have entered the training phase.
Randomization
Upon entering the study, participants will receive a sealed
envelope containing an exterior subject number that will
be used for registration purposes during the assessment
sessions in the lab (baseline, post-training, and follow-up).
The envelope will contain a training manual, an URL that
directs participants to the online training task, and a
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personal training task identification code that should be
used while performing the ten online training sessions at
home. Prior to the study, an independent researcher will
randomly link the training task identification codes to the
subject numbers that will be used in the lab using an auto-
mated randomization program (RandList; randomisatio-
n.eu). This researcher will prepare the envelopes and keep
a list of the linked subject numbers and training session
identification codes in a locked closet at the office and a
copy at home for safe keeping. Based on the training task
identification codes, participants will either perform the
CCT or low cognitive load training.
Blinding
We present a double blind RCT design. Prior to the
randomization procedure, the independent researcher will
reset the online training task so that even-numbered train-
ing task identification codes will redirect the participants to
one condition (CCT or active control), whereas odd-
numbered training task identification codes will redirect
the participants to the other condition. The researchers of
this study will not be aware of the training task identifica-
tion codes (these are randomly generated and presented in
a sealed envelope) or the link between even- or odd-
numbered identification codes and training condition. Fur-
thermore, participants will be instructed not to share details
concerning the content of the training task or the personal
training task identification code with the researchers.
During data-analysis, the researchers will remain blind
of training task condition by separating (a) analysis of
training task performance and process measures (based
on even- or odd-numbered training task identification
codes) from (b) analysis of training effects on the outcome
measures. Concerning the latter, the independent re-
searcher will provide the researchers with a list grouping
the subject numbers — used during the lab sessions — in
two non-informative conditions following completion of
data-collection. Importantly, at this point (lab) subject
numbers will not be linked to the personal training task
identification codes. This allows blind evaluation of train-
ing effects. The blinding will only be broken for the more
explorative analyses linking training task process measures
with the outcome measures. Furthermore, we will use the
CEQ-data to check for successful blinding of participants.
Analysis
In line with Consolidated Standards of Reporting Trials
(CONSORT; [47]), we will use intention-to-treat (ITT)
analysis to test effects of CCT on primary and secondary
measures post-training and at follow-up. Missing data will
be handled using the Last-Observation-Carried-Forward
(LOCF) method. Effects of CCT will be tested using Re-
peated Measures, analysis of variance (ANOVA), or co-
variance (ANCOVA) with follow-up t-tests. Exploratory
analysis will take into account potential moderators of
training effects such as variability in baseline depressive
symptomatology and cognitive control. ITT might not ne-
cessarily apply to the exploratory analyses such as analysis
of process measures of training. As secondary analysis, we
will also perform completers-only analyses. Explorative
within-group mediation analysis will be performed using a
stepwise regression approach [48] and the Preacher and
Hayes [49] bootstrapping method.
Procedure
Eligibility will be assessed by a clinical psychologist. Par-
ticipants will first undergo a telephone screening to as-
sess eligibility (see Fig. 1). Second, potential participants
will be invited to the lab where eligibility will be further
assessed using the MINI. After giving informed consent,
eligible participants will be randomized and the baseline
assessment will take place (see Table 1). At baseline (Time
1), the behavior measure for cognitive control will be
completed followed by the self-report measure for cogni-
tive control (BRIEF-A). Next, participants will complete
the other self-report questionnaires (primary outcome
measures: BDI-II, RRS; secondary outcome measures:
CERQ, QLDS, WHODAS 2.0, RS, RDQ) and will receive
psycho-education concerning cognitive training for de-
pression and practical information about the intervention.
Participants will be instructed to complete 10 training ses-
sions during a period of 14 days following the baseline as-
sessment and will be asked to perform only one session a
day. At the end of the baseline assessment session, the
CEQ will be administered and participants’ telephone
number will be registered using SurveySignal software.
During the 14-days period of online training, participants
will receive a daily automated text message reminding
them to complete the training. Each training session will
consist of 400 trials of the adaptive PASAT or a low cogni-
tive load training and will include assessments of affect
and worrying throughout and following training. Upon
completing training, participants will return to the lab for
the post-training assessment (Time 2) during which direct
effects of CCT on cognitive control and the primary out-
come measures and adaptive emotion regulation will be
assessed. At the end of the post-training session the CEQ
will be administered to rule out group differences in ex-
pectancy and credibility of the intervention. Finally, partic-
ipants will return to the lab at three months follow-up
(Time 3) during which long-term effects on cognitive con-
trol and the primary and secondary outcome measures
(including indicators of functioning) will be assessed. At
each time point we will assess stressful life events (LTE), in-
take of antidepressants and other forms of therapy. Upon
completion of the follow-up assessment session, partici-
pants will receive reimbursement (€75) followed by a partial
written and oral debriefing. Importantly, participants will
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only receive feedback concerning their condition following
processing of the data of the total sample. If CCT shows to
have beneficial effects in RMD, participants from the active
control condition will be offered the chance to perform the
CCT online.
Discussion
Prevention of recurrent depression is an important tar-
get for interventions. Previous findings indicate that
CCT shows potential in reducing depressive symptom-
atology and rumination in MDD as well as cognitive vul-
nerability in at-risk undergraduate students. To test the
potential of CCT as a preventive intervention for depres-
sion, the present study aims to test the effectiveness of
CCT in a RMD sample. We will test whether CCT tar-
geting working memory functioning — as compared to a
low cognitive load training — can be used to reduce vul-
nerability for depression over a 3.5 months period. We
hypothesize that CCT will have beneficial effects on pri-
mary outcome measures depressive rumination (i.e., brood-
ing) and depressive symptomatology and hope to see these
findings extend to adaptive emotion regulation and long-
term functioning (secondary outcome measures).
This double blind RCT study forms a first test of the po-
tential of CCT as a preventive intervention for depression
in RMD. Furthermore, these findings will be informative to
the literature as several exploratory questions will be ad-
dressed in order to further elucidate the role of cognitive
control in vulnerability for depression. First, we will explore
whether effects of CCT on depressive symptomatology are
mediated by rumination. Second, we will explore whether
effects of CCT extend to measures of adaptive emotion
regulation and indices of functioning such as quality of life
and disability. Third, in order to further elucidate the mech-
anisms involved during CCT, we could explore how process
measures of CCT relate to effects of training.
Overall, this study will further enhance the knowledge
on the role of cognitive control in emotion regulation
and vulnerability for depression. This study forms a first
step in testing the effectiveness of CCT targeting work-
ing memory functioning as a preventive intervention for
(recurrent) depression. If these first results show to be
promising, future work should focus on replicating the
effects of CCT and exploring how this preventive inter-
vention could best be implemented.
Trial status
We are currently recruiting RMD patients for this study.
The study entered the data collection phase in April 2015.
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Inclusion criteria interview X
MINI Screen and structured interview X
Process measures of training task experience X
Process measures of training task performance (ISI) X
Credibility and expectancy of treatment (CEQ) X X
Stressful life events (LTE) X X X
Self-reported use of antidepressants and other forms of
therapy
X X X
Cognitive control (non-adaptive PASAT / transfer task) X X X
Self-reported cognitive control (BRIEF-A) X X X
Depressive symptomatology (BDI-II) X X X
Depressive rumination (RRS) X X X
Cognitive emotion regulation (CERQ) X X X
Quality of Life (QLDS) X X
Disability (WHODAS 2.0) X X
Resilience (RS) X X
Remission from depression (RDQ) X X
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